Periodic Reporting for period 1 - AuriMod (From pills to bio-electronics: a wearable anti-inflammatory treatment for prevention of Peripheral Arterial Disease.)
Reporting period: 2018-01-01 to 2018-04-30
With its AuriMod device, SzeleSTIM offers an innovative patient-centred, non-invasive pain management system based on electrical stimulation of the vagus nerve in the ear. Its unique biofeedback-controlled algorithm uses patient real-time physiological data for automatically adjusting the therapy. In this way, SzeleSTIM paves the way for truly individualised therapy, based on the patient’s individual condition and dynamic needs. In addition to pain management, other potential future applications of the AuriMod device include vascular diseases such as Peripheral Arterial Disease (PAD), but also migraine, or autoimmune diseases.